ERS Statement: Exercise testing in the evaluation of interventional efficacy

Luis Puente Maestu (Madrid, Spain)

Source: International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Luis Puente Maestu (Madrid, Spain). ERS Statement: Exercise testing in the evaluation of interventional efficacy. International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
Source: Eur Respir J 2016; 47: 429-460
Year: 2016



Optimizing experimental research in respiratory diseases: an ERS Statement
Source: International Congress 2018 – Organoids and pluripotent stem cells
Year: 2018


ERS Statement on Interventional bronchoscopy in children
Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology
Year: 2017


ERS Statement on standardisation of cardiopulmonary exercise testing (CPET) in chronic lung diseases
Source: International Congress 2019 – Clinical Year in review
Year: 2019


Genetic associations is part of the personalised answer: Report of ERS Statement on AATD
Source: International Congress 2017 – Personalised care for emphysema in COPD
Year: 2017


ERS statement on paediatric long-term noninvasive respiratory support
Source: Guideline 2022
Year: 2021

ERS School Course Basic principles of clinical exercise testing - Clinical exercise testing
Source: ISSN=ISSN 1810-6838, ISBN=, page=159
Year: 2006

Cardiopulmonary exercise testing preoperative assessment: Physician perspectives
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010

ERS Statement on Respiratory Muscle Testing at Rest and during Exercise
Source: Guideline 2019
Year: 2019

ERS Statement: Diagnosis and treatment of primary spontaneous pneumothorax
Source: International Congress 2015 – ERS Task Forces and Guidelines: procedures, methodology and publication
Year: 2015



Exercise testing in the evaluation of interventions
Source: Annual Congress 2008 - PG16 - Basic principles of cardiopulmonary exercise testing and interpretation
Year: 2008



Quality of resistance training description in COPD trials: Study protocol for a systematic review
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016


Exercise testing for pre-operative evaluation
Source: Eur Respir Monogr 2018; 80: 251-279
Year: 2018


Exercise testing for the evaluation of pharmacological interventions in clinical practice
Source: Annual Congress 2013 –PG14 Cardiopulmonary exercise testing in the evaluation of patients with respiratory diseases
Year: 2013


Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Eur Respir J 2016; 48: 648-663
Year: 2016




Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Guideline 2017
Year: 2017

Exercise testing for the evaluation of interventions in clinical practice and trials
Source: Annual Congress 2010 - PG18 Postgraduate Course: Cardiopulmonary exercise testing in the evaluation of the respiratory patient
Year: 2010

Value and use of field exercise tests in diagnosis, prognosis and treatment: an update from the Task Force on field exercise tests
Source: International Congress 2014 – What is emerging from ERS Task Forces in terms of outcome measures for adult respiratory disease
Year: 2014